Reference Source

Bell, Sons & Co. (Druggists) Ltd. · 66-41 · UNITED KINGDOM

For Bell, Sons & Co. (Druggists) Ltd. · 66-41 · UNITED KINGDOM, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is UNITED KINGDOM; product is Silver Bird 100 % Eucalyptus Oil B.P. | Menthodex Cough Mixture | Menthodex Cough Mixture | Menthodex Cough Mixture | Menthodex Cough Mixture | Silver Bird 100 % Eucalyptus Oil B.P; product code is 55 P - - 93 Eucalyptus Oil (Pharmaceutic Necessity - Flavor) | 60 B - - 01 Ammonium Chloride (Acidifier) | 62 M - - 08 Menthol (Anti-Pruritic) | 62 U - - 99 Anti-Tussive/Cold N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/15/2021; address is Gifford House , Slaidburn Crescent , Southport, Merseyside UNITED KINGDOM, verified against its source on 2026-09-16.

Firm
Bell, Sons & Co. (Druggists) Ltd. verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
UNITED KINGDOM verified
Address
Gifford House , Slaidburn Crescent , Southport, Merseyside UNITED KINGDOM verified
Date published
09/15/2021 verified
Product code
55 P - - 93 Eucalyptus Oil (Pharmaceutic Necessity - Flavor) | 60 B - - 01 Ammonium Chloride (Acidifier) | 62 M - - 08 Menthol (Anti-Pruritic) | 62 U - - 99 Anti-Tussive/Cold N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
Product
Silver Bird 100 % Eucalyptus Oil B.P. | Menthodex Cough Mixture | Menthodex Cough Mixture | Menthodex Cough Mixture | Menthodex Cough Mixture | Silver Bird 100 % Eucalyptus Oil B.P. each item verified
FDA notes
The product appears to be a drug, as per section 201(g)(1) of the FD&C Act, 21 U.S.C. § 321(g)(1) because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or to affect the structure or any function of the body. A labeling statement documenting the intended use of the product include, but may not be limited to, the following: “A natural remedy for colds, coughs, catarrh and headaches.” | The product appears to be a drug, as per section 201(g)(1) of the FD&C Act, 21 U.S.C. § 321(g)(1) because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or to affect the structure or any function of the body. A labeling statement documenting the intended use of the product include, but may not be limited to, the following: “A natural remedy for colds, coughs, catarrh and headaches.” each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Bell, Sons & Co. (Druggists) Ltd. Date Published : 09/15/2021 Gifford House , Slaidburn Crescent , Southport, Merseyside UNITED KINGDOM 55 P - - 93 Eucalyptus Oil (Pharmaceutic Necessity - Flavor) Date Published: 09/15/2021 Desc: Silver Bird 100 % Eucalyptus Oil B.P. Notes: The product appears to be a drug, as per section 201(g)(1) of the FD&C Act, 21 U.S.C. § 321(g)(1) because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or to affect the structure or any function of the body. A labeling statement documenting the intended use of the product include, but may not be limited to, the following: “A natural remedy for colds, coughs, catarrh and headaches.” 60 B - - 01 Ammonium Chloride (Acidifier) Date Published: 09/27/2021 Desc: Menthodex Cough Mixture 62 M - - 08 Menthol (Anti-Pruritic) Date Published: 09/27/2021 Desc: Menthodex Cough Mixture 62 U - - 99 Anti-Tussive/Cold N.E.C. Date Published: 09/27/2021 Desc: Menthodex Cough Mixture 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 09/27/2021 Desc: Menthodex Cough Mixture 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 09/15/2021 Desc: Silver Bird 100 % Eucalyptus Oil B.P. Notes: The product appears to be a drug, as per section 201(g)(1) of the FD&C Act, 21 U.S.C. § 321(g)(1) because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or to affect the structure or any function of the body. A labeling statement documenting the intended use of the product include, but may not be limited to, the following: “A natural remedy for colds, coughs, catarrh and headaches.”

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.